๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A phase II study of m-AMSA in patients with primary liver cancer

โœ Scribed by Geoffrey Falkson; Buks Coetzer; David J. Klaassen

Publisher
Springer
Year
1981
Tongue
English
Weight
261 KB
Volume
6
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Phase II studies of mitoxantrone in pati
Phase II studies of mitoxantrone in patients with primary liver cancer
โœ Geoffrey Falkson; Barend Johannes Coetzer ๐Ÿ“‚ Article ๐Ÿ“… 1985 ๐Ÿ› Springer US ๐ŸŒ English โš– 147 KB

Forty-nine patients with histologically conlirmed primary liver cancer have been entered on phase II trials of mitoxantrone (NovantroneC"~; dihydroxyanthracenedione), at a dose of 14 mg/m 2 every 3 weeks. Among the patients evaluable for toxicity, leukopenia and thrombocytopenia were the most import

Phase II study of ionidamine in patients
Phase II study of ionidamine in patients with metastatic breast cancer
โœ H. Ian Robins; Donna S. Neuberg; Al B. Benson; Kishan J. Pandya; Douglass C. Tor ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› Springer US ๐ŸŒ English โš– 193 KB

The Eastern Cooperative Oncology Group conducted a phase II study of lonidamine in patients with metastatic breast cancer. The drug was given orally to a maximum daily dose of 340 mg/m 2. Forty-two patients were entered on study. One partial response was observed; there were no life-threatening toxi